Aehr Test Systems Rises as Investors Revisit AI Order Momentum and Backlog

Aehr Test Systems (AEHR) is up 5.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued investor interest in Aehr’s AI and silicon photonics growth story rather than a brand-new same-day catalyst. Recent company updates highlighted a large AI-related follow-on order, expanding silicon photonics production activity, and a sizable backlog that supports aggressive fiscal 2027 growth expectations. This could also be because investors are positioning ahead of management’s October 13, 2026 investor summit appearance.

Details:

In August, the company announced a $22 million follow-on production order from its lead AI processor customer for wafer-level burn-in systems, with shipments expected over the following six months.

Another August update showed a follow-on production order from a lead silicon photonics customer, reinforcing Aehr’s exposure to AI data-center optical interconnect demand.

In July, Aehr reported record quarterly bookings of $60.7 million and an effective backlog of about $100.6 million, which management said provided visibility into projected fiscal 2027 revenue of $130 million to $150 million.

A late-September announcement confirmed management will participate in an investor summit on October 13, keeping the company in focus with shareholders and analysts.

Sources:

Aehr Test Systems, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AEHR Insider Trading Activity

$AEHR insiders have traded $AEHR stock on the open market 61 times in the past 6 months. Of those trades, 0 have been purchases and 61 have been sales.

Here’s a breakdown of recent trading of $AEHR stock by insiders over the last 6 months:

GAYN ERICKSON (President and CEO) has made 0 purchases and 4 sales selling 192,824 shares for an estimated $16,020,509.
GEOFFREY GATES SCOTT (Director) has made 0 purchases and 7 sales selling 135,000 shares for an estimated $12,306,020.
RHEA J POSEDEL (Director) has made 0 purchases and 9 sales selling 100,892 shares for an estimated $9,129,021.
HOWARD T SLAYEN (Director) has made 0 purchases and 4 sales selling 57,519 shares for an estimated $5,763,340.
ALBERTO SALAMONE (EVP, PPBI BUSINESS) has made 0 purchases and 4 sales selling 39,672 shares for an estimated $3,997,237.
VERNON ROGERS (Exec VP of Sales & Mktg.) has made 0 purchases and 8 sales selling 35,799 shares for an estimated $3,322,837.
ADIL ENGINEER (Chief Operating Officer) has made 0 purchases and 6 sales selling 31,813 shares for an estimated $3,104,724.
DONALD P. II RICHMOND (CTO) has made 0 purchases and 2 sales selling 32,762 shares for an estimated $2,326,659.
FARIBA DANESH (Director) has made 0 purchases and 3 sales selling 18,500 shares for an estimated $1,406,628.
LAURA OLIPHANT (Director) has made 0 purchases and 4 sales selling 11,098 shares for an estimated $972,623.
ALISTAIR N SPORCK (VP Contactor Business Unit) has made 0 purchases and 6 sales selling 9,000 shares for an estimated $795,886.
DIDIER WIMMERS (Executive VP of R&D) has made 0 purchases and 2 sales selling 5,400 shares for an estimated $385,731.
CHRIS SIU (CFO) has made 0 purchases and 2 sales selling 2,070 shares for an estimated $221,608.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive AEHR Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$AEHR Hedge Fund Activity

We have seen 167 institutional investors add shares of $AEHR stock to their portfolio, and 93 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AWM INVESTMENT COMPANY, INC. removed 1,219,163 shares (-76.5%) from their portfolio in Q2 2026, for an estimated $117,112,797
FMR LLC removed 1,135,809 shares (-53.0%) from their portfolio in Q2 2026, for an estimated $109,105,812
BAILLIE GIFFORD & CO removed 1,086,856 shares (-84.2%) from their portfolio in Q2 2026, for an estimated $104,403,387
TWO SIGMA INVESTMENTS, LP added 950,242 shares (+443.3%) to their portfolio in Q2 2026, for an estimated $91,280,246
D. E. SHAW & CO., INC. added 887,130 shares (+305.6%) to their portfolio in Q2 2026, for an estimated $85,217,707
PRICE T ROWE ASSOCIATES INC /MD/ removed 842,316 shares (-62.4%) from their portfolio in Q2 2026, for an estimated $80,912,874
JPMORGAN CHASE & CO added 732,547 shares (+inf%) to their portfolio in Q2 2026, for an estimated $70,368,464

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.